Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Eva de Rijke, Martien L. Essers, Jeroen C.W. Rijk, Mario Thevis, Toine F.H. Bovee, Leendert A. van Ginkel & Saskia S. Sterk. (2013) Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis. Food Additives & Contaminants: Part A 30:9, pages 1517-1526.
Read now
Read now
Michael L Mohler, Ramesh Narayanan, Christopher C Coss, Kejiang Hu, Yali He, Zhongzhi Wu, Seoung-Soo Hong, Dong Jin Hwang, Duane D Miller & James T Dalton. (2010) Estrogen receptor β selective nonsteroidal estrogens: seeking clinical indications. Expert Opinion on Therapeutic Patents 20:4, pages 507-534.
Read now
Read now
Xuqing Zhang, James C Lanter & Zhihua Sui. (2009) Recent advances in the development of selective androgen receptor modulators. Expert Opinion on Therapeutic Patents 19:9, pages 1239-1258.
Read now
Read now
Gordon S Lynch. (2008) Update on emerging drugs for sarcopenia – age-related muscle wasting. Expert Opinion on Emerging Drugs 13:4, pages 655-673.
Read now
Read now
Emily Pfeil & Adrian S Dobs. (2008) Current and future testosterone delivery systems for treatment of the hypogonadal male. Expert Opinion on Drug Delivery 5:4, pages 471-481.
Read now
Read now
Daniel Edelstein, Mala Sivanandy, Sadeka Shahani & Shehzad Basaria. (2007) The latest options and future agents for treating male hypogonadism. Expert Opinion on Pharmacotherapy 8:17, pages 2991-3008.
Read now
Read now
Daniel Edelstein, Adrian Dobs & Shehzad Basaria. (2006) Emerging drugs for hypogonadism. Expert Opinion on Emerging Drugs 11:4, pages 685-707.
Read now
Read now
Articles from other publishers (31)
K. O. Böker, M. Komrakova, L. Fahrendorff, B. R. Spelsberg, D. B. Hoffmann, A. F. Schilling, W. Lehmann, S. Taudien & S. Sehmisch. (2023) Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model. Endocrine 81:3, pages 579-591.
Crossref
Crossref
A. Kaufmann, A. Arrizabalaga-Larrañaga, M.H. Blokland & S.S. Sterk. (2023) Potential and limitation of retrospective HRMS based data analysis: “Have meat-producing animals been exposed to illegal growth promotors such as SARMs?”. Food Control 147, pages 109611.
Crossref
Crossref
Marina Komrakova, Judith Furtwängler, Daniel Bernd Hoffmann, Wolfgang Lehmann, Arndt Friedrich Schilling & Stephan Sehmisch. (2019) The Selective Androgen Receptor Modulator Ostarine Improves Bone Healing in Ovariectomized Rats. Calcified Tissue International 106:2, pages 147-157.
Crossref
Crossref
Emiliano Ventura, Anna Gadaj, Gail Monteith, Alexis Ripoche, Jim Healy, Francesco Botrè, Saskia S. Sterk, Tom Buckley & Mark H. Mooney. (2019) Development and validation of a semi-quantitative ultra-high performance liquid chromatography-tandem mass spectrometry method for screening of selective androgen receptor modulators in urine. Journal of Chromatography A 1600, pages 183-196.
Crossref
Crossref
Peter Y. Liu & Johannes D. Veldhuis. 2019. Yen and Jaffe's Reproductive Endocrinology. Yen and Jaffe's Reproductive Endocrinology
285
300.e8
.
Stephan Haehling. (2017) Wasting away: How to treat cachexia and muscle wasting in chronic disease?. British Journal of Clinical Pharmacology 83:12, pages 2599-2601.
Crossref
Crossref
Kyle J. Hackney, Jessica M. Scott, Andrea M. Hanson, Kirk L. English, Meghan E. Downs & Lori L. Ploutz-Snyder. (2015) The Astronaut-Athlete. Journal of Strength and Conditioning Research 29:12, pages 3531-3545.
Crossref
Crossref
Steven Karch & Olaf Drummer. 2015. Karch's Pathology of Drug Abuse, Fifth Edition. Karch's Pathology of Drug Abuse, Fifth Edition
755
784
.
Peter Y. Liu & Johannes D. Veldhuis. 2014. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology
272
286.e8
.
Heinrich Burkhardt. 2013. Drug Therapy for the Elderly. Drug Therapy for the Elderly
303
309
.
Christopher C. Coss, Matt Bauler, Ramesh Narayanan, Duane D. Miller & James T. Dalton. (2011) Alanine Aminotransferase Regulation by Androgens in Non-hepatic Tissues. Pharmaceutical Research 29:4, pages 1046-1056.
Crossref
Crossref
Shayne Cox GadGregory T. Wurz & Michael W. DeGregorio. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Dimitrios D. Nikolopoulos, Chara Spiliopoulou & Stamatios E. Theocharis. (2011) Doping and musculoskeletal system: short-term and long-lasting effects of doping agents. Fundamental & Clinical Pharmacology 25:5, pages 535-563.
Crossref
Crossref
Shontelle DodsonVickie E. BaracosAminah JatoiWilliam J. EvansDavid CellaJames T. DaltonMitchell S. Steiner. (2011) Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies. Annual Review of Medicine 62:1, pages 265-279.
Crossref
Crossref
Azriel Schmidt, Donald B. Kimmel, Chang Bai, Angela Scafonas, SuJane Rutledge, Robert L. Vogel, Sheila McElwee-Witmer, Fang Chen, Pascale V. Nantermet, Viera Kasparcova, Chih-tai Leu, Hai-Zhuan Zhang, Mark E. Duggan, Michael A. Gentile, Paul Hodor, Brenda Pennypacker, Patricia Masarachia, Evan E. Opas, Sharon A. Adamski, Tara E. Cusick, Jiabing Wang, Helen J. Mitchell, Yuntae Kim, Thomayant Prueksaritanont, James J. Perkins, Robert S. Meissner, George D. Hartman, Leonard P. Freedman, Shun-ichi Harada & William J. Ray. (2010) Discovery of the Selective Androgen Receptor Modulator MK-0773 Using a Rational Development Strategy Based on Differential Transcriptional Requirements for Androgenic Anabolism Versus Reproductive Physiology. Journal of Biological Chemistry 285:22, pages 17054-17064.
Crossref
Crossref
Roberta Diaz Brinton. 2010. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Brocklehurst's Textbook of Geriatric Medicine and Gerontology
163
169
.
Kirk J. Brower. 2011. Addiction Medicine. Addiction Medicine
533
549
.
Robert M. Johnston, Linda N. Chu, Mark Liu, Steven L. Goldberg, Animesh Goswami & Ramesh N. Patel. (2009) Hydroxylation of l-proline to cis-3-hydroxy-l-proline by recombinant Escherichia coli expressing a synthetic l-proline-3-hydroxylase gene. Enzyme and Microbial Technology 45:6-7, pages 484-490.
Crossref
Crossref
Mihail F Zilbermint & Adrian S Dobs. (2009)
Nonsteroidal selective androgen receptor modulator Ostarine
™
in cancer cachexia
. Future Oncology 5:8, pages 1211-1220.
Crossref
Crossref
Jay R Hoffman, William J Kraemer, Shalender Bhasin, Thomas Storer, Nicholas A Ratamess, G Gregory Haff, Darryn S Willoughby & Alan D Rogol. (2009) Position Stand on Androgen and Human Growth Hormone Use. Journal of Strength and Conditioning Research 23:Supplement 5, pages S1-S59.
Crossref
Crossref
Michael L. Mohler, Casey E. Bohl, Amanda Jones, Christopher C. Coss, Ramesh Narayanan, Yali He, Dong Jin Hwang, James T. Dalton & Duane D. Miller. (2009) Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit. Journal of Medicinal Chemistry 52:12, pages 3597-3617.
Crossref
Crossref
Peter Y. Liu & Johannes D. Veldhuis. 2009. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology
283
298
.
Michael L. Mohler, Casey E. Bohl, Ramesh Narayanan, Yali He, Dong Jin Hwang, James T. Dalton & Duane D. Miller. 2008. Nuclear Receptors as Drug Targets. Nuclear Receptors as Drug Targets
249
304
.
G N Brooke, M G Parker & C L Bevan. (2007) Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. Oncogene 27:21, pages 2941-2950.
Crossref
Crossref
RLYKA DRESNER-POLLAK, S. AUBREY STOCH & MICHAEL ROSENBLATT. 2008. Osteoporosis. Osteoporosis
1837
1895
.
Xuqing Zhang, Xiaojie Li, George F. Allan, Tifanie Sbriscia, Olivia Linton, Scott G. Lundeen & Zhihua Sui. (2007) Design, Synthesis, and in Vivo SAR of a Novel Series of Pyrazolines as Potent Selective Androgen Receptor Modulators. Journal of Medicinal Chemistry 50:16, pages 3857-3869.
Crossref
Crossref
Monty Montano, John N. Flanagan, Lan Jiang, Paola Sebastiani, Matthew Rarick, Nathan K. LeBrasseur, Carl A. Morris, Ravi Jasuja & Shalender Bhasin. (2007) Transcriptional Profiling of Testosterone-Regulated Genes in the Skeletal Muscle of Human Immunodeficiency Virus-Infected Men Experiencing Weight Loss. The Journal of Clinical Endocrinology & Metabolism 92:7, pages 2793-2802.
Crossref
Crossref
Lawrence G. Hamann, Mark C. Manfredi, Chongqing Sun, Stanley R. KrystekJr.Jr., Yanting Huang, Yingzhi Bi, David J. Augeri, Tammy Wang, Yan Zou, David. A. Betebenner, Aberra Fura, Ramakrishna Seethala, Rajasree Golla, Joyce E. Kuhns, John A. Lupisella, Celia J. Darienzo, Laura L. Custer, Jennifer L. Price, James M. Johnson, Scott A. Biller, Robert Zahler & Jacek Ostrowski. (2007) Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators. Bioorganic & Medicinal Chemistry Letters 17:7, pages 1860-1864.
Crossref
Crossref
Gordon S. Lynch, Jonathan D. Schertzer & James G. Ryall. (2007) Therapeutic approaches for muscle wasting disorders. Pharmacology & Therapeutics 113:3, pages 461-487.
Crossref
Crossref
Wenqing Gao & James T. Dalton. (2007) Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discovery Today 12:5-6, pages 241-248.
Crossref
Crossref
Raymond A. Ng, James C. Lanter, Vernon C. Alford, George F. Allan, Tifanie Sbriscia, Scott G. Lundeen & Zhihua Sui. (2007) Synthesis of potent and tissue-selective androgen receptor modulators (SARMs): 2-(2,2,2)-Trifluoroethyl-benzimidazole scaffold. Bioorganic & Medicinal Chemistry Letters 17:6, pages 1784-1787.
Crossref
Crossref